150 related articles for article (PubMed ID: 19702571)
21. ERK1/2 and p38 MAP kinases control prion protein fragment 90-231-induced astrocyte proliferation and microglia activation.
Thellung S; Villa V; Corsaro A; Pellistri F; Venezia V; Russo C; Aceto A; Robello M; Florio T
Glia; 2007 Nov; 55(14):1469-85. PubMed ID: 17705195
[TBL] [Abstract][Full Text] [Related]
22. Neuropathology of prion diseases.
Budka H
Br Med Bull; 2003; 66():121-30. PubMed ID: 14522854
[TBL] [Abstract][Full Text] [Related]
23. Identifying therapeutic targets and treatments in model systems.
Lasmézas C; Gabizon R
Handb Clin Neurol; 2018; 153():409-418. PubMed ID: 29887148
[TBL] [Abstract][Full Text] [Related]
24. Persistent retroviral infection with MoMuLV influences neuropathological signature and phenotype of prion disease.
Krasemann S; Neumann M; Luepke JP; Grashorn J; Wurr S; Stocking C; Glatzel M
Acta Neuropathol; 2012 Jul; 124(1):111-26. PubMed ID: 22271154
[TBL] [Abstract][Full Text] [Related]
25. Pathogenesis of prion diseases.
Unterberger U; Voigtländer T; Budka H
Acta Neuropathol; 2005 Jan; 109(1):32-48. PubMed ID: 15645262
[TBL] [Abstract][Full Text] [Related]
26. Prions and peripheral nerves: a deadly rendezvous.
Heikenwalder M; Julius C; Aguzzi A
J Neurosci Res; 2007 Sep; 85(12):2714-25. PubMed ID: 17393538
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanisms of neurotoxicity of pathological prion protein.
Castilla J; Hetz C; Soto C
Curr Mol Med; 2004 Jun; 4(4):397-403. PubMed ID: 15354870
[TBL] [Abstract][Full Text] [Related]
28. The neurochemical nature of PrP(c)-containing cells in the rat brain.
Moleres FJ; Velayos JL
Brain Res; 2007 Oct; 1174():143-51. PubMed ID: 17854776
[TBL] [Abstract][Full Text] [Related]
29. Cells and prions: a license to replicate.
Nuvolone M; Aguzzi A; Heikenwalder M
FEBS Lett; 2009 Aug; 583(16):2674-84. PubMed ID: 19527722
[TBL] [Abstract][Full Text] [Related]
30. Decreased cell surface prion protein in mouse models of prion disease.
Griffin JK; Terry LA; Jackman R; Yousefi M; Cashman NR
Neuroreport; 2007 Jan; 18(1):1-6. PubMed ID: 17259851
[TBL] [Abstract][Full Text] [Related]
31. Adult human microglia secrete cytokines when exposed to neurotoxic prion protein peptide: no intermediary role for prostaglandin E2.
Veerhuis R; Hoozemans JJ; Janssen I; Boshuizen RS; Langeveld JP; Eikelenboom P
Brain Res; 2002 Jan; 925(2):195-203. PubMed ID: 11792368
[TBL] [Abstract][Full Text] [Related]
32. Effect of Microglial Inflammation in Prion Disease.
Ano Y; Sakudo A; Onodera T
Curr Issues Mol Biol; 2020; 36():1-12. PubMed ID: 31486773
[TBL] [Abstract][Full Text] [Related]
33. In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate.
Faburay B; Tark D; Kanthasamy AG; Richt JA
Prion; 2014; 8(6):393-403. PubMed ID: 25495764
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory response of microglia to prions is controlled by sialylation of PrP
Srivastava S; Katorcha E; Makarava N; Barrett JP; Loane DJ; Baskakov IV
Sci Rep; 2018 Jul; 8(1):11326. PubMed ID: 30054538
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.
Kim DH; Lee HM; Ryou C
J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058
[TBL] [Abstract][Full Text] [Related]
36. Contribution of neuropathology to the understanding of human prion disease.
Kovács GG; Kalev O; Budka H
Folia Neuropathol; 2004; 42 Suppl A():69-76. PubMed ID: 15449461
[TBL] [Abstract][Full Text] [Related]
37. Amino acid sequence and prion strain specific effects on the in vitro and in vivo convertibility of ovine/murine and bovine/murine prion protein chimeras.
Kupfer L; Eiden M; Buschmann A; Groschup MH
Biochim Biophys Acta; 2007 Jun; 1772(6):704-13. PubMed ID: 17145171
[TBL] [Abstract][Full Text] [Related]
38. Brain targeting through the autonomous nervous system: lessons from prion diseases.
Haïk S; Faucheux BA; Hauw JJ
Trends Mol Med; 2004 Mar; 10(3):107-12. PubMed ID: 15106608
[TBL] [Abstract][Full Text] [Related]
39. Enhanced neuroinvasion by smaller, soluble prions.
Bett C; Lawrence J; Kurt TD; Orru C; Aguilar-Calvo P; Kincaid AE; Surewicz WK; Caughey B; Wu C; Sigurdson CJ
Acta Neuropathol Commun; 2017 Apr; 5(1):32. PubMed ID: 28431576
[TBL] [Abstract][Full Text] [Related]
40. [Biology of non-conventional transmissible agents or prions].
Dormont D
Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
